Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Vicapsys Life Sciences Total Liabilities (Quarterly) : 3.682M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.682M |
| March 31, 2025 | 3.070M |
| December 31, 2024 | 2.894M |
| September 30, 2024 | 2.735M |
| June 30, 2024 | 2.446M |
| March 31, 2024 | 2.256M |
| December 31, 2023 | 1.968M |
| September 30, 2023 | 1.542M |
| June 30, 2023 | 1.472M |
| March 31, 2023 | 1.205M |
| December 31, 2022 | 1.023M |
| September 30, 2022 | 0.9041M |
| June 30, 2022 | 0.8488M |
| March 31, 2022 | 0.7658M |
| December 31, 2021 | 0.716M |
| September 30, 2021 | 0.746M |
| June 30, 2021 | 0.8212M |
| March 31, 2021 | 0.8262M |
| December 31, 2020 | 0.8532M |
| September 30, 2020 | 0.7839M |
| June 30, 2020 | 0.7107M |
| March 31, 2020 | 0.5181M |
| December 31, 2019 | 0.3965M |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | 1.05M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1325M |
| Shareholders Equity (Quarterly) | -3.549M |
| Debt to Equity Ratio | -0.1759 |
| Current Ratio | 0.036 |
| Net Debt Paydown Yield | -0.07% |